Su-Jung Park Selected Research

Su-Jung Park Research Topics

Disease

10	Neoplasms (Cancer) 10/2022 - 11/2002
4	Neurilemmoma (Schwannoma) 12/2021 - 01/2015
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2011 - 07/2004
2	Hypersensitivity (Allergy) 01/2013 - 07/2004
2	Fanconi Anemia (Fanconi's Anemia) 09/2011 - 07/2004
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2011 - 12/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Carcinoma (Carcinomatosis) 10/2022
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Sepsis (Septicemia) 01/2022
1	Infections 01/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Acoustic Neuroma (Acoustic Neurinoma) 12/2021
1	Fatigue 01/2021
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2021
1	Hypothyroidism 01/2021
1	Pain (Aches) 01/2021
1	Neurofibromatoses (Neurofibromatosis) 01/2021
1	Plexiform Neurofibroma 01/2021
1	Burns 12/2020
1	Bone Resorption 07/2018
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2018
1	Sensorineural Hearing Loss 01/2018
1	Tooth Discoloration 04/2015
1	Synovitis 04/2014
1	Arthritis (Polyarthritis) 04/2014
1	Aneuploidy (Aneuploid) 09/2013
1	Smear Layer 07/2013
1	Brain Neoplasms (Brain Tumor) 06/2013
1	Septic Shock (Toxic Shock Syndrome) 01/2013
1	Leukemia 01/2013
1	Asthma (Bronchial Asthma) 01/2013
1	Ankylosing Spondylitis 08/2012
1	Virus Diseases (Viral Diseases) 09/2011
1	Cardiofaciocutaneous syndrome 01/2011
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2011
1	Xeroderma Pigmentosum (Kaposi's Disease) 03/2006
1	Complementation Group E Xeroderma Pigmentosum 03/2006
1	Chromosomal Instability (Chromosome Stability) 07/2004
1	Chromosome Breakage 02/2004
1	Breast Neoplasms (Breast Cancer) 11/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 09/2013 - 03/2006
4	DNA (Deoxyribonucleic Acid)IBA 03/2006 - 11/2002
3	CaspasesIBA 10/2022 - 09/2011
2	Neurofibromin 2 (Merlin)IBA 12/2021 - 01/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2013 - 01/2011
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2022
1	protein kinase modulatorIBA 10/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Protein Isoforms (Isoforms)IBA 12/2021
1	CytokinesIBA 01/2021
1	propacetamolIBA 01/2021
1	cabozantinibIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Tartrate-Resistant Acid PhosphataseIBA 07/2018
1	LigandsIBA 07/2018
1	Celecoxib (Celebrex)FDA Link 01/2018
1	calcium silicate (Wollastonite)IBA 04/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014
1	osteoblast cadherinIBA 04/2014
1	Edetic Acid (EDTA)FDA Link 07/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2013
1	Immunoglobulin E (IgE)IBA 01/2013
1	AllergensIBA 01/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2013
1	LeptinIBA 08/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2011
1	Neurofibromin 1 (Neurofibromin)IBA 12/2008
1	ChromatinIBA 02/2004
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2004
1	Peptides (Polypeptides)IBA 11/2002
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2002
1	DNA-Activated Protein KinaseIBA 11/2002
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 11/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2013
1	Drug Tapering 01/2021
1	Dental Pulp Capping 04/2015
1	Drug Therapy (Chemotherapy) 11/2002